Stratus Appoints Dr. Selim Benbadis and Dr. Omotola Hope to its Medical Advisory Board | National

The appointment of Selim Benbadis, MD, and Hope of OmotolaMD, will help support Stratus’ commitment to serving a diverse patient population.

DALLAS, August 25, 2022 /PRNewswire-PRWeb/ — Stratus announced the appointment of Selim Benbadis, MD, and Hope of Omotola, MD, to the company’s medical advisory board. Formed in 2018, Stratus’ Medical Advisory Board (MAB) provides critical advice and information to the company as it develops new neurodiagnostic services and solutions. The addition of Dr. Benbadis and Dr. Hope expands the diversity of Stratus’ MAB and supports the company’s commitment to serving a diverse patient population and expanding patient care and access.

“Dr. Benbadis’ experience with intractable seizures along with EEG video monitoring research and Dr. Hope’s expertise with comorbid conditions of epilepsy will bring a wealth of diverse knowledge to our board,” said Jeremy Slater, MD, Stratus Chief Medical Officer. “We are very pleased to have them join our Medical Advisory Board, as their in-depth knowledge of epilepsy will be crucial to Stratus as we continue to advance our EEG services and solutions for patients, physicians and hospital systems. »

Selim Benbadis, MD, is a board-certified epileptologist and clinical neurophysiologist. Benbadis is a graduate of the Faculty of Medicine of the University of Pleasant (Nice, France), where he completed a family medicine residency. He completed his neurology residency at the Cleveland Clinic Foundation where he remained for two additional years to complete a fellowship in epilepsy, EEG, and sleep medicine. Dr. Benbadis is currently Professor of Neurology at the University of South Florida and the director of University of South Florida /Tampa Comprehensive General Hospital Epilepsy Program. He is interested in the diagnosis and management of difficult-to-control seizures and the misdiagnosis of epilepsy. He is the author of over two hundred articles and book chapters. He also has a keen interest in medical writing and editing and sits on several editorial boards. Finally, he is very interested in education, teaches many courses each year and has received several teaching awards.

Hope of Omotola, MD, is a board-certified neurologist who specializes in the treatment of epilepsy and other types of seizures. Hope graduated from University of Pennsylvania Medicine School. She completed an internship in internal medicine at North Shore University Hospital in Manhasset, NYand his neurology residency at Yale New Haven Hospital in Connecticut. She also completed an epilepsy fellowship at Yale New Haven Hospital, as well as a fellowship in the Robert Wood Johnson Clinical Scholars Program at Yale University School of Medicine. She currently treats patients at Houston Methodist Sugar Land and was previously at Memorial Hermann Hospital, where she also served as associate professor of neurology and director of the epilepsy research program at McGovern Medical School in University of Texas Health Sciences Center – Houston.

For more information about the Stratus Medical Advisory Board and a complete list of its members, please visit the company’s website:


About Stratus

Stratus is the nation’s leading provider of EEG solutions and has served more than 98,000 patients across the United States. The company offers proprietary technology, services and software solutions to help neurologists diagnose their patients with epilepsy and other seizure-like disorders accurately and quickly. Stratus also provides mobile cardiac telemetry to meet the diagnostic testing needs of the neurological community. Additionally, the company’s R&D division holds the world’s largest database of anonymized EEG recordings and applies machine learning to improve the overall quality and efficiency of EEG testing. To learn more, visit

Media Contact

Jennifer ArmstrongStratus, 1-972-743-8992, [email protected]

Stratus SOURCE

About Michael Bill

Check Also

Reverse Dravet Restoration of SCN1A Gene Activity in a Mouse Model | Seizures stopped, further gains seen even after symptom onset

Restoring the activity of Scn1a – a murine variant of the gene that is often …